TCP
TVTX icon

TAMRO Capital Partners’s Travere Therapeutics TVTX Stock Holding History

TAMRO Capital Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$8.5M Sell
440,868
-210,360
-32% -$4.2M 2.31% 15
2015
Q3 		$13.2M Buy
651,228
+398,069
+157% +$11.8M 1.5% 42
2015
Q2 		$8.39M Buy
+253,159
New +$6.93M 0.72% 54

Other funds holding TVTX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAMRO Capital Partners's TVTX Position: Q4 2015 in Review

TAMRO Capital Partners reduced its Travere Therapeutics (TVTX) stake by 32% in Q4 2015, selling an estimated $4.2M and leaving 440,868 shares worth $8.5M. The position accounts for 2.31% of the portfolio, ranked #15.

TAMRO Capital Partners first reported a position in TVTX in Q2 2015 and has held it in 3 quarters since. The position peaked at $13.2M in Q3 2015. 116 funds tracked by Wall St. Rank hold TVTX as of Q4 2015.

  • TAMRO Capital Partners held 440,868 shares of Travere Therapeutics worth $8.5M as of Q4 2015.
  • TAMRO Capital Partners sold 210,360 Travere Therapeutics shares in Q4 2015, an estimated $4.2M.
  • Travere Therapeutics made up 2.31% of TAMRO Capital Partners's portfolio in Q4 2015, its #15 holding.
  • TAMRO Capital Partners first reported a position in Travere Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • TAMRO Capital Partners's Travere Therapeutics position peaked at $13.2M in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2015.

Based on TAMRO Capital Partners's 13F filing for Q4 2015, filed 21 Jan 2016.